Huber Martin H. Jr.
SEC CIK 1653276 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | Dir | 103.0K | $45.0K | — | 6 | 2022-02-02 | 2026-02-04 |
Most active insiders at SNDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Metzger Michael A | CEO, Dir | — | $1.43M |
| 2 | Botwood Nicholas A.J. | CMO, Head of R, D | — | $1.18M |
| 3 | Goldan Keith A. | CFO | — | $137.0K |
| 4 | Rizo Aleksandra | Dir | — | — |
| 5 | Jarrett Jennifer | Dir | — | — |
| 6 | Huber Martin H. Jr. | Dir | — | — |
| 7 | Legault Pierre | Dir | — | — |
| 8 | Katkin Keith | Dir | — | — |
| 9 | Podlesak Dennis | Dir | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-06 | 2026-02-04 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +24.0K | 103.0K | +30% | $0 | |
| 2025-05-19 | 2025-05-19 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | P - Purchase | $8.99 | +5,000 | 79.0K | +7% | +$45.0K | |
| 2025-02-07 | 2025-02-05 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +25.0K | 74.0K | +51% | $0 | |
| 2024-02-09 | 2024-02-07 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +17.0K | 49.0K | +53% | $0 | |
| 2023-02-03 | 2023-02-02 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +16.0K | 32.0K | +100% | $0 | |
| 2022-02-03 | 2022-02-02 | SNDX | Syndax Pharmaceuticals Inc | Huber Martin H. Jr. | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations